mitomycin has been researched along with Ache in 16 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Strontium-89 is an established alternative for the alleviation of bone pain in prostate cancer." | 9.11 | Palliation of bone pain in prostate cancer using chemotherapy and strontium-89. A randomized phase II study. ( Edgren, M; Ginman, C; Kälkner, KM; Nilsson, S; Nordström, B; Ryberg, M; Strang, P; Westlin, JE; Zimmermann, R, 2005) |
| "Newer radiation techniques, and the application of continuous 5-FU exposure during radiation therapy using oral capecitabine may improve the treatment of anal cancer." | 5.17 | Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study. ( Beijnen, JH; Boot, H; Cats, A; Deenen, MJ; Dewit, L; Schellens, JH, 2013) |
| "In contrast to earlier reports HAP and CAI with MMC and Melphalan did not demonstrate any benefit in terms of tumour response, median survival and pain reduction, compared to less invasive treatment options." | 5.11 | Balloon catheter hypoxic abdominal perfusion with Mitomycin C and Melphalan for locally advanced pancreatic cancer: a phase I-II trial. ( de Bruijn, EA; Eggermont, AM; Guetens, G; Jeekel, J; ten Hagen, TL; van Eijck, CH; van Etten, B; van IJken, MG, 2004) |
| "Strontium-89 is an established alternative for the alleviation of bone pain in prostate cancer." | 5.11 | Palliation of bone pain in prostate cancer using chemotherapy and strontium-89. A randomized phase II study. ( Edgren, M; Ginman, C; Kälkner, KM; Nilsson, S; Nordström, B; Ryberg, M; Strang, P; Westlin, JE; Zimmermann, R, 2005) |
| "Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
| "To report a prospective controlled study to compare the acceptance of two different ways of administering intravesical mitomycin C, as the immediate intravesical administration of chemotherapy after surgery decreases the risk of recurrence in patients with superficial bladder cancer, but response rates are variable, partly because of inadequate drug delivery and thus an adequate administration time is important for optimum oncological efficacy." | 3.74 | Increasing patient comfort by optimized postoperative administration of intravesical mitomycin C. ( Granig, T; Mueller, T; Steiner, H; Stoehr, B; Zangerl, F, 2008) |
| "Fourteen cases of adenocarcinoma with pleuritis carcinomatosa (lung cancer 10 cases, ovarian cancer 2 cases, colon cancer 2 cases) were treated with intra-pleural instillation of 7-N-(p-hydroxyphenyl)-mitomycin C (KW-2083), a derivative of mitomycin C." | 3.67 | [Effect of 7-N-(P-hydroxyphenyl)-mitomycin C (KW-2083) against pleuritis carcinomatosa]. ( Eguchi, K; Garcia-Herreros, P; Hoshi, A; Nomori, H; Saijo, N; Sasaki, Y; Shimizu, E; Shinkai, T; Tominaga, K, 1984) |
| "Effect of this treatment on the pain could be evaluated in 16 patients." | 1.27 | Palliation of pelvic recurrence of colorectal cancer with intra-arterial 5-fluorouracil and mitomycin. ( Chuang, VP; Claghorn, L; Mavligit, G; Patt, YZ; Peters, RE; Wallace, S, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (18.75) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Baron, E | 1 |
| Velez-Mejia, C | 1 |
| Sittig, M | 1 |
| Spiliotis, J | 1 |
| Nikiforchin, A | 1 |
| Lopez-Ramirez, F | 1 |
| Gushchin, V | 1 |
| Sardi, A | 1 |
| Çilesiz, NC | 1 |
| Özkan, A | 1 |
| Kalkanlı, A | 1 |
| Gezmiş, CT | 1 |
| Yazıcı, G | 1 |
| Onuk, Ö | 1 |
| Nuhoğlu, B | 1 |
| Siracusano, S | 1 |
| Silvestri, T | 1 |
| Bassi, S | 1 |
| Porcaro, AB | 1 |
| Cerruto, MA | 1 |
| Talamini, R | 1 |
| Artibani, W | 1 |
| Deenen, MJ | 1 |
| Dewit, L | 1 |
| Boot, H | 1 |
| Beijnen, JH | 1 |
| Schellens, JH | 1 |
| Cats, A | 1 |
| Abdul Aziz, NH | 1 |
| Wang, W | 1 |
| Teo, MC | 1 |
| Stoehr, B | 1 |
| Mueller, T | 1 |
| Granig, T | 1 |
| Zangerl, F | 1 |
| Steiner, H | 1 |
| Tebbutt, NC | 2 |
| Norman, A | 2 |
| Cunningham, D | 2 |
| Iveson, T | 1 |
| Seymour, M | 1 |
| Hickish, T | 1 |
| Harper, P | 1 |
| Maisey, N | 1 |
| Mochlinski, K | 1 |
| Prior, Y | 1 |
| Hill, M | 2 |
| Sacharczuk, M | 1 |
| Jaszczak, K | 1 |
| Sadowski, B | 1 |
| Kelleher, M | 1 |
| Andreyev, J | 1 |
| Allen, M | 1 |
| van IJken, MG | 1 |
| van Etten, B | 1 |
| Guetens, G | 1 |
| ten Hagen, TL | 1 |
| Jeekel, J | 1 |
| de Bruijn, EA | 1 |
| Eggermont, AM | 1 |
| van Eijck, CH | 1 |
| Nilsson, S | 1 |
| Strang, P | 1 |
| Ginman, C | 1 |
| Zimmermann, R | 1 |
| Edgren, M | 1 |
| Nordström, B | 1 |
| Ryberg, M | 1 |
| Kälkner, KM | 1 |
| Westlin, JE | 1 |
| Babaian, RJ | 1 |
| Hsu, SD | 1 |
| Shimizu, E | 1 |
| Saijo, N | 1 |
| Shinkai, T | 1 |
| Eguchi, K | 1 |
| Tominaga, K | 1 |
| Nomori, H | 1 |
| Sasaki, Y | 1 |
| Garcia-Herreros, P | 1 |
| Hoshi, A | 1 |
| Kersten, RC | 1 |
| Kulwin, DR | 1 |
| Patt, YZ | 1 |
| Peters, RE | 1 |
| Chuang, VP | 1 |
| Wallace, S | 1 |
| Claghorn, L | 1 |
| Mavligit, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II, Randomised Study of Nivolumab as Consolidation Therapy in Patients With Locally Advanced, Unresectable Non-Small Cell Lung Cancer (Stage III) Who Have Not Progressed Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent C[NCT04085250] | Phase 2 | 264 participants (Actual) | Interventional | 2019-11-28 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for mitomycin and Ache
6 trials available for mitomycin and Ache
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; C | 2013 |
A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Proto | 2002 |
Mitomycin C, carboplatin and protracted venous infusion 5-fluorouracil in advanced oesophago-gastric and pancreatic cancer: results of two phase II studies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Esophageal Neoplasms; Fema | 2003 |
Balloon catheter hypoxic abdominal perfusion with Mitomycin C and Melphalan for locally advanced pancreatic cancer: a phase I-II trial.
Topics: Aged; Antineoplastic Agents; Balloon Occlusion; Chemotherapy, Cancer, Regional Perfusion; Female; Hu | 2004 |
Palliation of bone pain in prostate cancer using chemotherapy and strontium-89. A randomized phase II study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Double-Blind Method; Epirubici | 2005 |
10 other studies available for mitomycin and Ache
| Article | Year |
|---|---|
Delayed genital necrosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with Mitomycin-C.
Topics: Anti-Bacterial Agents; Antibiotics, Antineoplastic; Combined Modality Therapy; Cytoreduction Surgica | 2021 |
Spinal Anesthesia Provides Longer Administration Time for Postoperative Intravesical Chemotherapy after TUR-B Operation.
Topics: Administration, Intravesical; Anesthesia, Spinal; Humans; Mitomycin; Pain; Urinary Bladder Neoplasms | 2022 |
Health-related quality of life after BCG or MMC induction for non-muscle invasive bladder cancer.
Topics: Adjuvants, Immunologic; Administration, Intravesical; Adult; Age Factors; Aged; Aged, 80 and over; A | 2018 |
Scrotal pain and ulceration post HIPEC: a case report.
Topics: Adult; Cytoreduction Surgical Procedures; Gastrointestinal Neoplasms; Genital Diseases, Male; Humans | 2015 |
Increasing patient comfort by optimized postoperative administration of intravesical mitomycin C.
Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemother | 2008 |
Cytogenetic comparison of the sensitivity to mutagens in mice selected for high (HA) and low (LA) swim stress-induced analgesia.
Topics: Analgesia; Animals; Bone Marrow Cells; Chromosome Aberrations; Cytogenetics; DNA Repair; Gamma Rays; | 2003 |
Chemotherapy of hormone-refractory carcinoma of prostate with 5-fluorouracil, adriamycin, and mitomycin C.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Castration; Doxorubicin; Estro | 1984 |
[Effect of 7-N-(P-hydroxyphenyl)-mitomycin C (KW-2083) against pleuritis carcinomatosa].
Topics: Adenocarcinoma; Adult; Aged; Anorexia; Antineoplastic Agents; Colonic Neoplasms; Female; Fever; Huma | 1984 |
MMC in ONS decompression.
Topics: Adolescent; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Humans; Male; Mitomycin; Myelin S | 1996 |
Palliation of pelvic recurrence of colorectal cancer with intra-arterial 5-fluorouracil and mitomycin.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; C | 1985 |